Form 8-K - Current report:
SEC Accession No. 0001140361-25-022574
Filing Date
2025-06-16
Accepted
2025-06-16 12:01:06
Documents
39
Period of Report
2025-06-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20050576_8k.htm   iXBRL 8-K 31801
2 EXHIBIT 99.1 ef20050576_ex99-1.htm EX-99.1 47841
6 ef20050576_ex99-1slide1.jpg GRAPHIC 131674
7 ef20050576_ex99-1slide2.jpg GRAPHIC 95551
8 ef20050576_ex99-1slide3.jpg GRAPHIC 71168
9 ef20050576_ex99-1slide4.jpg GRAPHIC 87684
10 ef20050576_ex99-1slide5.jpg GRAPHIC 157959
11 ef20050576_ex99-1slide6.jpg GRAPHIC 156942
12 ef20050576_ex99-1slide7.jpg GRAPHIC 72130
13 ef20050576_ex99-1slide8.jpg GRAPHIC 196888
14 ef20050576_ex99-1slide9.jpg GRAPHIC 142298
15 ef20050576_ex99-1slide10.jpg GRAPHIC 196285
16 ef20050576_ex99-1slide11.jpg GRAPHIC 152073
17 ef20050576_ex99-1slide12.jpg GRAPHIC 118659
18 ef20050576_ex99-1slide13.jpg GRAPHIC 84656
19 ef20050576_ex99-1slide14.jpg GRAPHIC 111478
20 ef20050576_ex99-1slide15.jpg GRAPHIC 138482
21 ef20050576_ex99-1slide16.jpg GRAPHIC 144554
22 ef20050576_ex99-1slide17.jpg GRAPHIC 137579
23 ef20050576_ex99-1slide18.jpg GRAPHIC 137641
24 ef20050576_ex99-1slide19.jpg GRAPHIC 110045
25 ef20050576_ex99-1slide20.jpg GRAPHIC 106889
26 ef20050576_ex99-1slide21.jpg GRAPHIC 84427
27 ef20050576_ex99-1slide22.jpg GRAPHIC 129277
28 ef20050576_ex99-1slide23.jpg GRAPHIC 93299
29 ef20050576_ex99-1slide24.jpg GRAPHIC 130232
30 ef20050576_ex99-1slide25.jpg GRAPHIC 105437
31 ef20050576_ex99-1slide26.jpg GRAPHIC 111402
  Complete submission text file 0001140361-25-022574.txt   4636787

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA galt-20250616.xsd EX-101.SCH 3901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20250616_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20250616_pre.xml EX-101.PRE 16068
42 EXTRACTED XBRL INSTANCE DOCUMENT ef20050576_8k_htm.xml XML 4244
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 251049076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)